Daniella Kranjac (She/Her)

Daniella Kranjac is a Founding General Partner at Dynamk Capital. Daniella led Dynamk Capital’s investments in CellFE Biotech, Envisagenics, FloDesign Sonics (acquired by Millipore Sigma), RoosterBio, Virica Biotech, Xcell Biosciences, and others.

Prior to founding Dynamk Capital, she was CEO and Founder of Dynamk Consulting, providing capital, strategy and business development consulting to leading life science companies and startups.

Before that she was an entrepreneur and co-founded Wave Biotech LLC driving the start-up, growth and commercialization of a highly disruptive technology. As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in 2007 (now Danaher/Cytiva).

At GE Healthcare, Daniella held a variety of strategic, M&A and business development roles. One of her most notable achievements is the success in an entrepreneurial group within the broader GE Healthcare, where a focus on integrating the acquired Xcellerex business enabled global commercialization of a several hundred million dollar enterprise solutions business.

She holds a B.E. in Chemical Engineering from Stevens Institute of Technology and an Executive MBA from New York University Stern School of Business and has attended Harvard Business School Executive Education Courses in Private Equity & Venture Capital.